Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 284

    1.

    Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.

    Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas.

    Filaria J. 2003 Oct 24;2 Suppl 1:S2.

    PMID:
    14975059
    [PubMed - as supplied by publisher]
    Free PMC Article
    2.

    The Mectizan Donation Program (MDP).

    Thylefors B.

    Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:39-44.

    PMID:
    18718154
    [PubMed - indexed for MEDLINE]
    3.

    A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa.

    Addiss DG, Rheingans R, Twum-Danso NA, Richards FO.

    Filaria J. 2003 Oct 24;2 Suppl 1:S9.

    PMID:
    14975066
    [PubMed - as supplied by publisher]
    Free PMC Article
    4.

    Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.

    Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P.

    Filaria J. 2005 Apr 7;4(1):2.

    PMID:
    15817124
    [PubMed - as supplied by publisher]
    Free PMC Article
    5.

    Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

    Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux JP, Boussinesq M.

    Lancet. 1997 Jul 5;350(9070):18-22.

    PMID:
    9217715
    [PubMed - indexed for MEDLINE]
    7.

    Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.

    Twum-Danso NA.

    Filaria J. 2003 Oct 24;2 Suppl 1:S3.

    PMID:
    14975060
    [PubMed - as supplied by publisher]
    Free PMC Article
    8.

    Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.

    Twum-Danso NA, Meredith SE.

    Trop Med Int Health. 2003 Sep;8(9):820-31.

    PMID:
    12950668
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    The Mectizan Donation Program - highlights from 2005.

    Alleman MM, Twum-Danso NA, Thylefors BI.

    Filaria J. 2006 Sep 27;5:11.

    PMID:
    17005039
    [PubMed]
    Free PMC Article
    10.

    Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.

    Haselow NJ, Akame J, Evini C, Akongo S.

    Filaria J. 2003 Oct 24;2 Suppl 1:S10.

    PMID:
    14975067
    [PubMed - as supplied by publisher]
    Free PMC Article
    11.
    12.

    Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study.

    Higazi TB, Klion AD, Boussinesq M, Unnasch TR.

    Filaria J. 2004 Jun 29;3(1):4.

    PMID:
    15225348
    [PubMed - as supplied by publisher]
    Free PMC Article
    13.

    [Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].

    Kamgno J, Gardon J, Boussinesq M.

    Med Trop (Mars). 2000;60(3):275-7. French.

    PMID:
    11258063
    [PubMed - indexed for MEDLINE]
    14.

    Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.

    Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.

    Parasitology. 2006 Jul;133(Pt 1):101-9.

    PMID:
    16764737
    [PubMed - indexed for MEDLINE]
    15.

    Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.

    Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP.

    Am J Trop Med Hyg. 1998 Apr;58(4):461-9.

    PMID:
    9574793
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].

    Ducorps M, Gardon-Wendel N, Ranque S, Ndong W, Boussinesq M, Gardon J, Schneider D, Chippaux JP.

    Bull Soc Pathol Exot. 1995;88(3):105-12. French.

    PMID:
    8555762
    [PubMed - indexed for MEDLINE]
    17.

    Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control.

    Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, Enyong P, Remme JH, Molyneux DH, Boussinesq M.

    Filaria J. 2004 Aug 6;3(1):7.

    PMID:
    15298709
    [PubMed - as supplied by publisher]
    Free PMC Article
    18.

    Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.

    Bourguinat C, Kamgno J, Boussinesq M, Mackenzie CD, Prichard RK, Geary TG.

    Am J Trop Med Hyg. 2010 Jul;83(1):28-32.

    PMID:
    20595473
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.

    Colatrella B.

    Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:7-11.

    PMID:
    18718147
    [PubMed - indexed for MEDLINE]
    20.

    [Ivermectin].

    Boussinesq M.

    Med Trop (Mars). 2005;65(1):69-79. Review. French.

    PMID:
    15903082
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk